Clinical Trial Update: Efficacy and Safety of Oral NOMAC-E2 in Indian Women (P07057/MK-8175A-017) [Phase 3]

View source ↗

Summary

Phase 3 trial of oral NOMAC-E2 for contraception in Indian women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• NOMAC-E2 (nomegestrol acetate / 17β-estradiol)

Snippet

Sponsor: Organon and Co | Conditions: Contraception | Phase 3 | Status: WITHDRAWN